An electrocardiogram, commonly known as an EKG or ECG, is a test that measures the electrical activity of your heart. It's a ...

With the paid subscription, you also get additional benefits such as cloud storage, blood pressure monitoring, medication ...

In a time when pharmaceutical companies no longer have the economic luxury of decades-long development cycles, indication ...

AI revolutionizes heart failure screening with a cost-effective approach, enhancing early detection and patient outcomes in ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care ...

HeartBeam announced today that it received FDA 510(k) clearance for its comprehensive arrhythmia assessment system.

HeartBeam (BEAT) announced that the US Food and Drug Administration FDA has granted 510(k) clearance of the HeartBeam system for comprehensive ...

The study found that the novel model (known as 'AIRE'- AI-ECG risk estimation) can reliably predict all-cause mortality, ventricular arrhythmia, atherosclerotic CVD, and heart failure risk.

Earlier research showed that primary care clinicians using AI-ECG tools identified more unknown cases of a weak heart pump, also called low ejection fraction, than without AI. New study findings ...

In collaboration with nonprofit organization In a Heartbeat, approximately 150 students ages eight through 18 were provided with a free electrocardiogram (EKG) test. “A lot of heart diseases are ...

HeartSciences Inc. (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-powered medical technology company focused ...